Skip to main content
. 2023 Jul 17;11(10):343. doi: 10.21037/atm-22-5319

Table 2. Pain outcomes of participants in the DANPAIN-Biobank.

Variables Pain-free (n=70) High impact chronic pain (n=201) Osteoarthritis pain (n=81) P
Pain duration, years, median (25th–75th percentiles) 0 12.0 (6.5–21.8) 2.0 (1.0–4.0) <0.001
Peak pain intensity last week, NRS 0–10, mean (SD) 0 7.2 (1.8) 6.8 (2.1) 0.10
Average pain intensity last week, NRS 0–10, mean (SD) 0 5.7 (1.9) 5.5 (2.2) 0.56
Least pain intensity last week, NRS 0–10, mean (SD) 0 3.9 (2.1) 3.6 (2.6) 0.30
Pain intensity at physical activity last week, NRS 0–10 mean (SD) 0 6.3 (2.3) 6.4 (2.2) 0.77
Widespread pain index, pain sites, 0–19, mean (SD) 0 11.5 (5.1) 2.0 (1.3) <0.001
Pain diagnoses, n (%)
   Wide spread pain 0 143 (71%) 0
   Back pain 0 24 (12%) 0
   Osteoarthritic pain 0 0 81 (100%)
   Other 0 34 (17%) 0
Pain disability (PDI 5 items: 0–50, higher is worse), mean (SD) 0 37.1 (11.6) 26.1 (13.6) <0.001
PDI family/home responsibilities, 0–10 mean (SD) 0 6.4 (2.2) 4.8 (2.9) <0.001
PDI recreation 0–10, mean (SD) 0 7.3 (2.2) 6.9 (2.8) 0.2
PDI social activity 0–10, mean (SD) 0 6.3 (2.5) 4.1 (2.9) <0.001
PDI occupation 0–10, mean (SD) 0 7.1 (2.5) 4.4 (3.4) <0.001
PDI sexual behavior 0–10, mean (SD) 0 5.9 (3.0) 3.8 (3.4) <0.001
Analgesic treatment, n (%)
   No analgesic treatment 70 (100%) 22 (11%) 12 (15%)
   Paracetamol 0 130 (65%) 62 (77%)
   NSAID 0 52 (26%) 21 (26%)
   Opioid 0 67 (33%) 10 (12%)
   Antidepressants, pain indication 0 63 (31%) 1 (1%)
   Antiepileptics, pain indication 0 38 (19%) 2 (2%)
   Cannabinoids 0 11 (5%) 0
   Low dose naltrexone 0 11 (4%) 1 (1%)
   Local treatments 0 7 (3%) 0

, tricyclic antidepressants, duloxetine, venlafaxine; , transcutaneous electric nerve stimulation =2, Qutenza =1, Versatis =1, Botox =1, peripheral nerve field stimulation =1, spinal cord stimulation =1. P values represents differences between the two pain groups. DANPAIN, the Danish Pain Research Biobank; SD, standard deviation; NRS, Numerical Rating Scale; PDI, Pain Disability Index; NSAID, non-steroidal anti-inflammatory drugs.